ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 443

Sputum Anti-Citrullinated Protein Antibodies in Patients with Long Standing Rheumatoid Arthritis

Ari Polachek1, Wilma Vree Egberts2, Elizabeth Fireman3, Daphna Paran4, Ido Drokman5, Ilana Kaufman6, Irena Wigler7, Dan Caspi8, David Levartovsky9, Ger JM Pruijn10 and Ori Elkayam11, 1Rheumatology, Tel Aviv Medical Center, Tel Aviv, Israel, 2Radboud University Medical Centre, Nijmegen, Israel, 3Pulmonary and Allergic diseases, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, 4Rheumatology, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, 5Radiology, Sourasky Medical Center, Tel-Aviv, Israel, 6Sourasky Medical Center, Tel-Aviv, Israel, 7Department of Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 8Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 9Rheumatology, Tel Aviv Medical Ctr, Tel Aviv, Israel, 10Department of Biomolecular Chemistry, Radboud University, Nijmegen, Netherlands, 11Rheumatology, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ACPA and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: The lung has been implicated in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to evaluate the presence of autoantibodies to citrullinated (Cit) and non-citrullinated (Arg) forms of 2 cyclic synthetic peptides (ACPA) in the sputum of patients with long standing rheumatoid arthritis.

Methods: Twenty RA patients (80% female, mean age 62 years) and 15 age/gender matched healthy controls (81% female, mean age 58 years)  participated in this study. Demographic and epidemiological data, including age, gender, disease duration and smoking habits, were collected. All the subjects underwent complete lung function tests, and provided induced sputum. The severity of the disease was evaluated in the RA patients by means of DAS score, and hand and feet X rays. Antibodies to Cit and Arg peptides in the sputum of the RA patients and healthy controls, as well as in the serum of the RA patients, were determined by ELISA.

Results: The RA patients suffered from long standing disease (mean disease duration of 12 years), displayed moderate disease activity (mean DAS 3.44), and showed a mean Sharp van der Heijde score of 57.5. Seventy % of the patients were on DMARDs and 65% on biologics, mainly TNF alpha blockers. Sixty % and 68 % of the RA and healthy controls, respectively, were defined as “ever smoker”. Eleven of the 20 RA patients showed in most cases high titers of ACPA in their sera. Six of the seropositive (55%) and none of the seronegative RA patients and none of the healthy controls showed detectable levels of ACPA in their sputum. The ratio between the reactivity with Cit and Arg peptides in the sputum was significantly higher in RA sputum than in control sputum (1.33 +/- 1.2 vs. 0.64 +/- 0.14, p=0.02). A positive correlation was found between sputum ACPA and age and serum ACPA in RA patients, as well as between sputum anti-Cit/Arg reactivity ratio and the proportion of neutrophils and lymphocytes in the sputum. No significant correlation was found between sputum ACPA and disease severity, smoking or lung function tests.

Conclusion: ACPA can be detected in the sputum of RA patients and are correlated with the presence in the serum. These findings further strengthen the hypothesized role of the lungs in RA pathogenesis.


Disclosure:

A. Polachek,
None;

W. Vree Egberts,
None;

E. Fireman,
None;

D. Paran,
None;

I. Drokman,
None;

I. Kaufman,
None;

I. Wigler,
None;

D. Caspi,
None;

D. Levartovsky,
None;

G. J. Pruijn,
None;

O. Elkayam,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sputum-anti-citrullinated-protein-antibodies-in-patients-with-long-standing-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology